Other Publications Referenced in Amarin’s Investor Communications
Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolites.
Impact of expanded FDA indication for icosapent ethyl on enhanced cardiovascular residual risk reduction.
New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease
Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.